CUSIP 75886F107COMREGNQ4 2025
31 filings · latest Aug 6, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 9.08M | $7.00B |
| 2 | Blackrock, Inc. | 8.74M | $6.75B |
| 3 | State Street Corp | 4.66M | $3.60B |
| 4 | Dodge & Cox | 4.60M | $3.55B |
| 5 | Jpmorgan Chase & Co | 3.94M | $3.04B |
| 6 | Franklin Resources Inc | 2.56M | $1.98B |
| 7 | Geode Capital Management, LLC | 2.52M | $1.94B |
| 8 | Fmr LLC | 2.32M | $1.79B |
| 9 | Nuveen, LLC |
| 4 | Feb 12, 2025 | Fmr LLC | 13G/A | 7.6% | 8.19M | SEC |
| 5 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 8.3% | 8.84M | SEC |
| 6 | Feb 9, 2024 | Capital World Investors | 13G/A | 4.8% | 5.19M | SEC |
| 7 | Feb 9, 2024 | Fmr LLC | 13G/A | 9.6% | — | SEC |
| 8 | Jan 25, 2024 | Blackrock Inc. | 13G/A | 8.1% | 8.63M | SEC |
| 9 | Jan 25, 2024 | Jpmorgan Chase & Co | 13G/A | 6.7% | 7.22M | SEC |
| 10 | Jan 25, 2024 | Jpmorgan Chase & Co | 13G/A | 6.7% | 7.22M | SEC |
See the full Schedule 13D/13G history for Regeneron Pharmaceuticals.
Unlock full history| 2.01M |
| $1.55B |
| 10 | Loomis Sayles & Co L P | 1.93M | $1.49B |